BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8109994)

  • 1. [Neutron capture therapy for cancer].
    Fukuda H; Ichihashi M; Mishima Y
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin.
    Fukuda H; Hiratsuka J; Honda C; Kobayashi T; Yoshino K; Karashima H; Takahashi J; Abe Y; Kanda K; Ichihashi M
    Radiat Res; 1994 Jun; 138(3):435-42. PubMed ID: 8184019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human melanoma treated by boron neutron capture therapy: comparison of the clinical response with the predicted response.
    Hiratsuka J; Fukuda H; Kobayashi T; Kanda K; Honda C; Ichihashi M; Mishima Y
    Radiat Med; 1996; 14(5):257-63. PubMed ID: 8988505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine.
    Coderre JA; Joel DD; Micca PL; Nawrocky MM; Slatkin DN
    Radiat Res; 1992 Mar; 129(3):290-6. PubMed ID: 1542717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
    Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
    Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
    Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
    Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
    Coderre JA; Glass JD; Fairchild RG; Roy U; Cohen S; Fand I
    Cancer Res; 1987 Dec; 47(23):6377-83. PubMed ID: 3677082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
    Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
    Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective affinity of 10B1-paraboronophenylalanine-HCl to malignant melanoma: thermal neutron capture therapy].
    Tsuji M; Ichihashi M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1983 Jun; 93(7):773-8. PubMed ID: 6620640
    [No Abstract]   [Full Text] [Related]  

  • 14. The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster.
    Hiratsuka J; Fukuda H; Kobayashi T; Karashima H; Yoshino K; Imajo Y; Mishima Y
    Radiat Res; 1991 Nov; 128(2):186-91. PubMed ID: 1947014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BNCT for skin melanoma in extremities: updated Argentine clinical results.
    Menéndez PR; Roth BM; Pereira MD; Casal MR; González SJ; Feld DB; Santa Cruz GA; Kessler J; Longhino J; Blaumann H; Jiménez Rebagliati R; Calzetta Larrieu OA; Fernández C; Nievas SI; Liberman SJ
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S50-3. PubMed ID: 19375342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.
    Matalka KZ; Barth RF; Staubus AE; Moeschberger ML; Coderre JA
    Radiat Res; 1994 Jan; 137(1):44-51. PubMed ID: 8265787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM; Micca PL; Coderre JA
    Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance of normal human brain to boron neutron capture therapy.
    Coderre JA; Hopewell JW; Turcotte JC; Riley KJ; Binns PJ; Kiger WS; Harling OK
    Appl Radiat Isot; 2004 Nov; 61(5):1083-7. PubMed ID: 15308196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
    Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.